Inhibition of Human Plasminogen Kringle 5 on Growth and Metastasis of Lewis Lung Carcinoma in Vivo

蔡卫斌,程锐,徐祖敏,杨霞,杨中汉,魏玲,杨军,高国全
DOI: https://doi.org/10.3321/j.issn:1672-3554.2008.05.014
2008-01-01
Abstract:【Objective】 To investigate the inhibitory effects of human plasminogen kringle 5 (K5) on the growth and metastasis of mouse Lewis lung carcinoma (LLC) in vivo. 【Methods】 To evaluate K5 activity in vivo, the mouse lung cancer graft model was established by injection of Lewis lung carcinoma cells subcutaneously into the oxter of C57BL / 6J mice. On the 7th days after inoculation, the mice then received an intraperitoneal injection of K5 or phosphate buffered solution (PBS) as control. Tumor volume and mouse body weight were measured and plotted in tumor-volume curve and body-weight curve to estimate the tumor growth rate and general constitution of the animals during the course of treatment. A spontaneous metastasis mouse model of Lewis lung carcinoma was established by removing the primary tumors in the 7th days after inoculation. Right after the tumor remove, mice received K5 or PBS by intraperitoneal injection. The body weight and survival rate of both groups were recorded. After the mice were executed, the lungs were dissected, weighted, and undertaken a pathological analysis. 【Results】 The K5-treated group had a tumor growth rate which was significantly lower than that of the control group in grafted LLC mouse model, and distinctly depression of tumor weight [(4.57 ± 0.79) g, and (1.15 ± 0.31) g, respectively, P=0.006] and body weight. Compared to PBS-treated group, the incidence of metastasis to lung and the mean number of metastatic lung nodules (15.75 ± 9.79 and 6.60 ± 3.39 respectively, P=0.29) and the wet lung weight of each animal were reduced by K5 treatment in metastasis model of mouse Lewis lung carcinoma.Similarly, the pulmonary micrometastasis of K5-treated group decreased obviously with microscopic observation at high magnification. 【Conclusion】 K5 can inhibit the growth of Lewis lung carcinoma, and suppress the pulmonary metastasis of LLC cells in vivo.
What problem does this paper attempt to address?